Literature DB >> 17221046

High-density lipoproteins: metabolic, clinical, epidemiological and therapeutic intervention aspects. An update for clinicians.

Neusa Forti1, Jayme Diament.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17221046     DOI: 10.1590/s0066-782x2006001800019

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


× No keyword cloud information.
  4 in total

1.  Physical Activity and Lipid Profile in the ELSA- Brasil Study.

Authors:  Raquel Caroline da Silva; Maria de Fátima Haueisen Sander Diniz; Sheila Alvim; Pedro Guatimosim Vidigal; Ligia Maria Giongo Fedeli; Sandhi Maria Barreto
Journal:  Arq Bras Cardiol       Date:  2016-06-23       Impact factor: 2.000

2.  Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD.

Authors:  Laura Miranda de Oliveira Caram; Renata Ferrari; Cristiane Roberta Naves; Liana Sousa Coelho; Simone Alves do Vale; Suzana Erico Tanni; Irma Godoy
Journal:  J Bras Pneumol       Date:  2016 May-Jun       Impact factor: 2.624

Review 3.  Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?

Authors:  Marília Izar Helfenstein Fonseca; Isis Tande da Silva; Sandra Roberta G Ferreira
Journal:  Diabetol Metab Syndr       Date:  2017-04-07       Impact factor: 3.320

4.  The lipid components of high-density lipoproteins (HDL) are essential for the binding and transportation of antimicrobial peptides in human serum.

Authors:  Wen-Hung Tang; Shi-Han Wang; Chiu-Feng Wang; Yun Mou; Min-Guan Lin; Chwan-Deng Hsiao; You-Di Liao
Journal:  Sci Rep       Date:  2022-02-16       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.